Interestingly, it was recently shown that Mxi2 is highly expressed in prostate cancer, where it increases the aggressiveness of the disease, acting mainly by interacting with the Argonaut2/mir1285 complex that further regulate p53 activity [106]. The gene discussed is MAPK14; the disease is prostate cancer.